Pain Relief Patches

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse effects. The use of a heating pad concurrently is contraindicated as it may enhance absorption and increase the risk of systemic effects. Patients with known allergies to any ingredients in this product should avoid its use to prevent allergic reactions.

Additionally, contact with eyes, mucous membranes, or rashes must be avoided to prevent irritation. Tight bandaging is not recommended, as it may lead to increased local pressure and potential complications. Concurrent use with other topical analgesics is contraindicated to avoid additive effects and potential toxicity.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a doctor prior to use if they have a known allergy to aspirin or salicylates, as this product may provoke an allergic reaction in susceptible individuals.

General precautions must be observed to ensure safe application. The product should not be applied to wounds or damaged skin, as this may exacerbate irritation or lead to adverse effects. Additionally, it is contraindicated to use this product in conjunction with a heating pad, as this may increase the risk of skin irritation or burns. Patients should also be cautioned against use if they are allergic to any of the product's ingredients.

Patients should be instructed to discontinue use and seek medical advice if they experience any of the following: rash, itching, or excessive skin irritation. Furthermore, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, medical consultation is warranted.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. Individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In the event that patients experience a rash, itching, or excessive skin irritation, it is recommended that they discontinue use and seek medical advice. Additionally, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days, patients should also consult a healthcare provider. These precautions are essential to ensure patient safety and effective management of any adverse effects.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. It is essential to keep the product out of reach of children, as used patches still contain the drug and can pose serious risks if chewed or ingested. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For patients aged 12 years and older, the recommended application involves cleaning and drying the affected area before applying the patch. The patch should be applied to the affected area no more than 3 to 4 times daily and must be removed after a maximum of 8 hours of use. Proper disposal of used patches is crucial to prevent accidental exposure to children and pets.

Geriatric Use

Elderly patients may not have specific recommendations regarding age considerations, dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the potential for altered pharmacokinetics and pharmacodynamics in this population.

Pregnancy

Safety during pregnancy has not been established for this product. It is contraindicated in pregnant patients due to potential risks to the fetus associated with its use. Healthcare professionals should be aware of these risks when considering treatment options for women of childbearing potential. It is essential to weigh the benefits against the potential fetal impacts before prescribing this product to pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: rash, itching, and excessive skin irritation. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed that they must not use the product if they have a known allergy to any of its ingredients. They should be counseled to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be advised to stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using the product, patients should be reminded to follow the directions carefully. They should avoid contact with the eyes, mucous membranes, or rashes, and should not bandage the area tightly. It is also crucial to inform patients not to use the product simultaneously with other topical analgesics.

Finally, healthcare providers should emphasize the importance of proper disposal of used patches, ensuring that they are kept out of reach of children and pets, as used patches may still contain active ingredients that could lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and effectiveness.

After use, the patch must be disposed of properly to prevent access by children and pets, ensuring safety in the environment.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. The patch should be removed after a maximum application time of 8 hours. For children under 12 years of age, consultation with a physician is advised.

Clinicians should counsel patients on several important safety measures. Individuals with a history of allergic reactions to aspirin or salicylates should consult a doctor prior to use. Used patches must be disposed of properly to prevent access by children and pets, as they still contain active drug that could lead to serious adverse effects if ingested. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur after resolution. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if swallowed.

Drug Information (PDF)

This file contains official product information for Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)